Research Article
Serum Adiponectin Level as a Predictor of Subclinical Cushing’s Syndrome in Patients with Adrenal Incidentaloma
Table 4
Relationship of adiponectin with other parameters.
| | Adiponectin | | | rho | |
| Age | 69 | –0.077 | 0.532 | Adenoma diameter | 39 | –0.166 | 0.312 | Body mass index | 69 | –0.017 | 0.892 | Fasting blood glucose | 69 | –0.098 | 0.421 | Insulin | 58 | –0.387 | 0.003 | HOMA-IR | 58 | –0.391 | 0.002 | Total cholesterol | 65 | –0.191 | 0.127 | LDL-C | 66 | –0.235 | 0.057 | HDL-C | 65 | 0.386 | 0.001 | Triglycerides | 66 | –0.504 | <0.001 | Body fat percentage | 69 | 0.294 | 0.014 | Fat-free mass | 69 | –0.502 | <0.001 | Waist circumference | 69 | –0.23 | 0.057 | Waist-to-hip ratio | 69 | –0.159 | 0.192 | Basal cortisol | 69 | –0.112 | 0.361 | Midnight cortisol | 39 | –0.359 | 0.025 | ACTH | 65 | 0.284 | 0.022 | UFC | 25 | –0.372 | 0.067 | DHEAS | 36 | –0.402 | 0.015 |
|
|
HOMA-IR, homeostasis model assessment of insulin resistance; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; ACTH, adrenocorticotropic hormone; UFC, urinary free cortisol; DHEAS, dehydroepiandrosterone sulfate.
|